Literature DB >> 25253656

Profiling substrate specificity of two series of phenethylamine analogs at monoamine oxidase A and B.

Egon Heuson1, Morten Storgaard, Tri H V Huynh, Franck Charmantray, Thierry Gefflaut, Lennart Bunch.   

Abstract

The membrane bound enzyme monoamine oxidase exist in two splice variants designated A and B (MAO-A and MAO-B) and are key players in the oxidative metabolism of monoamines in mammalians. Despite their importance and being a prevalent target for the development of inhibitors as drugs, no systematic study of substrate specificity has been reported. In this study we present a systematic study of the MAO-A and MAO-B substrate specificity profile by probing two series of phenethylamine analogs. Km and kcat values were determined for four N-alkyl analogs 2-5 and four aryl halide analogs 6-9 at MAO-A and MAO-B. A following in silico study disclosed a new adjacent compartment to the MAO-B substrate pocket defined by amino acids Tyr188, Tyr435, Tyr398, Thr399, Cys172 and Gly434. This new insight is important for the understanding of the substrate specificity of the MAO-B enzyme and will be relevant for future drug design within the field of monoamines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25253656     DOI: 10.1039/c4ob01377h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Stereoselective Activity of 1-Propargyl-4-styrylpiperidine-like Analogues That Can Discriminate between Monoamine Oxidase Isoforms A and B.

Authors:  Damijan Knez; Natalia Colettis; Luca G Iacovino; Matej Sova; Anja Pišlar; Janez Konc; Samo Lešnik; Josefina Higgs; Fabiola Kamecki; Irene Mangialavori; Ana Dolšak; Simon Žakelj; Jurij Trontelj; Janko Kos; Claudia Binda; Mariel Marder; Stanislav Gobec
Journal:  J Med Chem       Date:  2020-01-22       Impact factor: 7.446

2.  Why p-OMe- and p-Cl-β-Methylphenethylamines Display Distinct Activities upon MAO-B Binding.

Authors:  Angélica Fierro; Dale E Edmondson; Cristian Celis-Barros; Marco Rebolledo-Fuentes; Gerald Zapata-Torres
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.